RBC Capital Markets updated its view on Reckitt Benckiser Group PLC (LON:RKT:LN) (OTC: RBGLY), a consumer goods giant with a $43.28 billion market cap, increasing the price target on the stock to £57.

RBC Capital Markets adjusted its outlook on Travelers Companies Inc. (NYSE:TRV) shares, reducing the price target to $268 from $273, while maintaining a Sector Perform rating. The $54.8 billion insurance giant,

In a research report released Friday, Mr. Kornack adjusted his earnings expectations across the sector to reflect a higher interest rate environment ahead of fourth-quarter 2024 earnings season. That led to his 2026 funds from operations per unit forecast declining by 1 per cent on average.

RBC Capital analyst Kenneth Herbert maintained a Buy rating on Boeing (BA – Research Report) today and set a price target of $200.00. The

RBC Capital Markets raised its recommendation on KB Home (NYSE:KBH) and Lennar (NYSE:LEN), considering the homebuilders' current valuation and as the investment bank sees a more balanced risk/reward. The stocks were upgraded to Sector Perform from ...

In a report released yesterday, Paul Treiber from RBC Capital maintained a Hold rating on Information Services (ISC – Research Report), with a

Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within the bank. Through summer jobs and co-op placements, as well as internships, they gain practical work experience and learn about RBC’s extensive career opportunities.

Investing.com -- RBC Capital Markets has downgraded both Anglo American (JO: AGLJ) plc and Antofagasta (LON: ANTO) plc to "underperform," citing valuation concerns, rising financial pressures, and challenges in key projects against a backdrop of heightened market risks.

The latest Market Talks covering Basic Materials. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0736 GMT – The relative attractiveness of Anglo American’s operational turnaround has somewhat diminished,

KeyBanc Capital Markets adjusted its price target on Inspire Medical Systems (NYSE:INSP) shares, lowering it to $234 from $236, while maintaining an Overweight rating on the stock. The revision follows Inspire Medical (TASE:PMCN)'s pre-announcement of its fourth-quarter results and initial guidance for the year 2025.

The yuan advanced alongside assets sensitive to China’s economy, amid signs that President Donald Trump is dialing back threats of slapping higher tariffs on exports there.

Stocks in the oil-and-gas sector fared better than the broader European market in a downbeat end to the year, with the Stoxx Europe 600 Oil & Gas sector index down 0.1% in the fourth quarter compared with the Stoxx Europe 600 index down 2.9% over the same period.